مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
Normal view MARC view ISBD view

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. [electronic resource]

By:
  • Szarc Vel Szic, Katarzyna
Contributor(s):
  • Declerck, Ken
  • Crans, René A J
  • Diddens, Jolien
  • Scherf, David B
  • Gerhäuser, Clarissa
  • Vanden Berghe, Wim
Producer: 20180402Description: 40434-40453 p. digitalISSN:
  • 1949-2553
Subject(s):
  • ADAM Proteins -- genetics
  • Antineoplastic Agents -- pharmacology
  • Azacitidine -- analogs & derivatives
  • Cell Line, Tumor
  • Cell Movement -- genetics
  • Cytokine TWEAK -- genetics
  • DNA Methylation -- genetics
  • Decitabine
  • Female
  • Glutathione Transferase -- genetics
  • Humans
  • MCF-7 Cells
  • Malate Dehydrogenase -- genetics
  • Membrane Proteins -- genetics
  • Receptor, ErbB-2 -- genetics
  • Receptors, Estrogen -- genetics
  • Receptors, Progesterone -- genetics
  • Triple Negative Breast Neoplasms -- drug therapy
  • Withanolides -- pharmacology
Online resources:
  • Available from publisher's website
In: Oncotarget vol. 8
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.

APA

Szarc Vel Szic K., Declerck K., Crans R. A. J., Diddens J., Scherf D. B., Gerhäuser C. & Vanden Berghe W. (20180402). Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. : Oncotarget.

Chicago

Szarc Vel Szic Katarzyna, Declerck Ken, Crans René A J, Diddens Jolien, Scherf David B, Gerhäuser Clarissa and Vanden Berghe Wim. 20180402. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. : Oncotarget.

Harvard

Szarc Vel Szic K., Declerck K., Crans R. A. J., Diddens J., Scherf D. B., Gerhäuser C. and Vanden Berghe W. (20180402). Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. : Oncotarget.

MLA

Szarc Vel Szic Katarzyna, Declerck Ken, Crans René A J, Diddens Jolien, Scherf David B, Gerhäuser Clarissa and Vanden Berghe Wim. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. : Oncotarget. 20180402.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site